About Remedium Therapeutics
Remedium Therapeutics is a Healthcare company based in Chennai (India). Drug development and herbal remedies for infectious diseases in India. Remedium Therapeutics has raised $126.08 thousand across 1 funding round. The company has 1 employees. Its Indian entity Remedium Therapeutics Private Limited reported revenue of ₹18.2 Lakh. Remedium Therapeutics offers products and services including COROQUIL-Zn and Herbal Remedies. Its focus areas include Pharmaceuticals, Drug Development, Herbal Medicine and Biotechnology.
Company details
Remedium Therapeutics is identified as a research-driven firm in drug development, where high-quality herbal remedies are provided for managing diseases and enhancing quality of life. Systematic scientific processes are applied to research, develop, and manufacture drugs targeting infectious diseases, with a focus on phytochemicals to create novel semi-synthetic and synthetic options that reduce adverse effects. The firms breakthrough product, COROQUIL-Zn, is noted for its role in adjuvant treatment of mild to moderate COVID-19, utilizing plant extracts to modulate immunity against respiratory issues. Insights from pharmacology are leveraged to address modern ailments effectively.
- Headquarters Chennai, India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website remediumtherapeutics.com
- Social X Instagram
- Legal Name Remedium Therapeutics Private Limited
- Date of Incorporation 01 Aug, 2020
- Jurisdiction Sriperumbudur, Tamil Nadu, India
- Annual Revenue₹18.2 Lakh
FY 2024 · +428% YoY
- Net Loss-₹37.2 Lakh
FY 2024 · -204% margin
- EBITDA-₹27.9 Lakh
FY 2024 · -153% margin
- Total Equity Funding$126.08K (USD)
in 1 rounds
- Latest Funding Round$126.08K (USD), Seed
Mar 2021
- Employee Count1
Associated legal entities of Remedium Therapeutics
Remedium Therapeutics operates through Remedium Therapeutics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Remedium Therapeutics Private Limited CIN U24297TN2020PTC136822 | Active | 01 Aug 2020 | Sriperumbudur, Tamil Nadu | ₹0.2 Cr | 2 | View details |
Products & Services of Remedium Therapeutics
Remedium Therapeutics offers a comprehensive portfolio of products and services, including COROQUIL-Zn and Herbal Remedies.
A product is formulated for lung support and immunity modulation against respiratory diseases
General remedies are developed for managing infectious diseases through scientific research processes
Funding Insights of Remedium Therapeutics
Remedium Therapeutics has successfully raised a total of $126.08K through 1 strategic funding round. The most recent funding activity was a Seed round of $126.08 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $126,084
- Total Rounds 1
- Last Round Seed — $126,084
- First Round $126,084
(Mar 2021)
All 1 funding rounds of Remedium Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $126,084 | Seed | – | – | – |
Board of directors of Remedium Therapeutics Private Limited (Remedium Therapeutics)
Remedium Therapeutics Private Limited is the primary company behind Remedium Therapeutics. The board of Remedium Therapeutics Private Limited currently have 2 directors; the longest-serving is Apparsundram Rajanikanth, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Apparsundram Rajanikanth DIN 06671547 | Director | 01 Aug 2020 | 6 yrs 3 mo | Remedium Therapeutics Private Limited |
| Ram Srinivasan DIN 02835588 | Director | 30 Sep 2022 | 4 yrs 1 mo | Remedium Therapeutics Private Limited |
Financials of Remedium Therapeutics
Figures of Remedium Therapeutics Private Limited, the primary company behind Remedium Therapeutics, for FY 2024. Revenue was ₹18.2 Lakh (+428% year on year). Net loss was -₹37.2 Lakh (-204% margin). EBITDA was -₹27.9 Lakh (-153% margin).
- ₹18.2 LakhRevenue · FY 2024 · +428% YoY
- -₹37.2 LakhNet loss · -204% margin
- -₹27.9 LakhEBITDA · -153% margin
- ₹31.7 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Remedium Therapeutics Private Limited are on its company page.
Detailed financial statements for Remedium Therapeutics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Remedium Therapeutics
Remedium Therapeutics is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Remedium Therapeutics is a funded company, having raised a total of $126.08K across 1 funding round to date. The company's 1st funding round was a Seed of $126.08K, raised on Mar 2021.
Remedium Therapeutics has 1 employees.
The primary company behind Remedium Therapeutics, Remedium Therapeutics Private Limited, reported revenue of ₹18.2 Lakh for FY 2024, up 428% year on year.
Remedium Therapeutics is identified as a research-driven firm in drug development, where high-quality herbal remedies are provided for managing diseases and enhancing quality of life. Systematic scientific processes are applied to research, develop, and manufacture drugs targeting infectious diseases, with a focus on phytochemicals to create novel semi-synthetic and synthetic options that reduce adverse effects. The firms breakthrough product, COROQUIL-Zn, is noted for its role in adjuvant treatment of mild to moderate COVID-19, utilizing plant extracts to modulate immunity against respiratory issues. Insights from pharmacology are leveraged to address modern ailments effectively.
Remedium Therapeutics offers COROQUIL-Zn and Herbal Remedies.
Remedium Therapeutics operates through Remedium Therapeutics Private Limited.
The legal entities of Remedium Therapeutics currently have 2 directors, including Apparsundram Rajanikanth, Ram Srinivasan.